Clinical trial
Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis (Complete - AS)
NCT01387802 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis (Complete - AS)
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 29, 2011
- Completion date
- December 16, 2019
- Enrollment
- 722 (actual)
- Sites
- 56
Conditions
As the registry lists them; a condition with its own page is linked.
ankylosing spondylitis